{"success":true,"data":{"pressRelease":{"id":"18950","rtpr_id":"nPn5hy8Tta","ticker":"BSX","exchange":"NYSE","all_tickers":["BSX"],"title":"Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results","author":"PR Newswire","published_at":"2026-05-04T12:00:17.299Z","article_body":"Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results\n\nPR Newswire\n\nMARLBOROUGH, Mass., May 4, 2026\n\nMARLBOROUGH, Mass., May 4, 2026 /PRNewswire/ -- Boston Scientific Corporation\n(NYSE: BSX) will participate in Bernstein's 42(nd) Annual Strategic Decisions\nConference on Wednesday, May 27, 2026. Mike Mahoney, chairman and chief\nexecutive officer, and Janar Sathananthan, M.D., chief medical officer,\nInterventional Cardiology Therapies, will participate in a 50-minute\nquestion-and-answer session with the host analyst at approximately 8:00 a.m.\nET.\n\n(https://mma.prnewswire.com/media/329537/Boston_Scientific_Logo.html)\n\nAdditionally, the company will webcast its conference call discussing\nfinancial results and business highlights for the second quarter ended June\n30, 2026, on Wednesday, July 29, 2026, at 8:00 a.m. ET. The call will be\nhosted by Mike Mahoney and Jon Monson, executive vice president and chief\nfinancial officer. The company will issue a news release announcing financial\nresults for the second quarter 2026 on July 29 prior to the conference call.\n\nA live webcast and replay for each event will be accessible at\nhttps://investors.bostonscientific.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4678716-1&h=722770642&u=https%3A%2F%2Finvestors.bostonscientific.com%2F&a=https%3A%2F%2Finvestors.bostonscientific.com)\n. The replays will be available approximately one hour following the\ncompletion of each event.\n\nAbout Boston Scientific\nBoston Scientific transforms lives through innovative medical technologies\nthat improve the health of patients around the world. As a global medical\ntechnology leader for more than 45 years, we advance science for life by\nproviding a broad range of high-performance solutions that address unmet\npatient needs and reduce the cost of healthcare. Our portfolio of devices and\ntherapies helps physicians diagnose and treat complex cardiovascular,\nrespiratory, digestive, oncological, neurological and urological diseases and\nconditions. Learn more at www.bostonscientific.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4678716-1&h=1651189033&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4498580-1%26h%3D475518601%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4007299-1%2526h%253D2437349916%2526u%253Dhttps%25253A%25252F%25252Fwww.bostonscientific.com%25252F%2526a%253Dwww.bostonscientific.com%26a%3Dwww.bostonscientific.com&a=www.bostonscientific.com)\n and follow us on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4678716-1&h=1771877107&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4498580-1%26h%3D3961625969%26u%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fboston-scientific%252F%26a%3DLinkedIn&a=LinkedIn)\n.\n\nCONTACTS:\nChanel Hastings\nMedia Relations\n+1 (508) 382-0288\nChanel.Hastings@bsci.com (mailto:Chanel.Hastings@bsci.com)\n\nLauren Tengler\nInvestor Relations\n+1 (508) 683-4479\nBSXInvestorRelations@bsci.com (mailto:BSXInvestorRelations@bsci.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-participation-in-bernsteins-42nd-annual-strategic-decisions-conference-and-conference-call-discussing-second-quarter-2026-results-302760793.html\n(https://www.prnewswire.com/news-releases/boston-scientific-announces-participation-in-bernsteins-42nd-annual-strategic-decisions-conference-and-conference-call-discussing-second-quarter-2026-results-302760793.html)\n\nSOURCE Boston Scientific Corporation\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/329537/Boston_Scientific_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn5hy8Tta","title":"Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results","author":"PR Newswire","ticker":"BSX","created":"2026-05-04T12:00:17.299Z","tickers":["BSX"],"exchange":"NYSE","article_body":"Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results\n\nPR Newswire\n\nMARLBOROUGH, Mass., May 4, 2026\n\nMARLBOROUGH, Mass., May 4, 2026 /PRNewswire/ -- Boston Scientific Corporation\n(NYSE: BSX) will participate in Bernstein's 42(nd) Annual Strategic Decisions\nConference on Wednesday, May 27, 2026. Mike Mahoney, chairman and chief\nexecutive officer, and Janar Sathananthan, M.D., chief medical officer,\nInterventional Cardiology Therapies, will participate in a 50-minute\nquestion-and-answer session with the host analyst at approximately 8:00 a.m.\nET.\n\n(https://mma.prnewswire.com/media/329537/Boston_Scientific_Logo.html)\n\nAdditionally, the company will webcast its conference call discussing\nfinancial results and business highlights for the second quarter ended June\n30, 2026, on Wednesday, July 29, 2026, at 8:00 a.m. ET. The call will be\nhosted by Mike Mahoney and Jon Monson, executive vice president and chief\nfinancial officer. The company will issue a news release announcing financial\nresults for the second quarter 2026 on July 29 prior to the conference call.\n\nA live webcast and replay for each event will be accessible at\nhttps://investors.bostonscientific.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4678716-1&h=722770642&u=https%3A%2F%2Finvestors.bostonscientific.com%2F&a=https%3A%2F%2Finvestors.bostonscientific.com)\n. The replays will be available approximately one hour following the\ncompletion of each event.\n\nAbout Boston Scientific\nBoston Scientific transforms lives through innovative medical technologies\nthat improve the health of patients around the world. As a global medical\ntechnology leader for more than 45 years, we advance science for life by\nproviding a broad range of high-performance solutions that address unmet\npatient needs and reduce the cost of healthcare. Our portfolio of devices and\ntherapies helps physicians diagnose and treat complex cardiovascular,\nrespiratory, digestive, oncological, neurological and urological diseases and\nconditions. Learn more at www.bostonscientific.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4678716-1&h=1651189033&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4498580-1%26h%3D475518601%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4007299-1%2526h%253D2437349916%2526u%253Dhttps%25253A%25252F%25252Fwww.bostonscientific.com%25252F%2526a%253Dwww.bostonscientific.com%26a%3Dwww.bostonscientific.com&a=www.bostonscientific.com)\n and follow us on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4678716-1&h=1771877107&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4498580-1%26h%3D3961625969%26u%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fboston-scientific%252F%26a%3DLinkedIn&a=LinkedIn)\n.\n\nCONTACTS:\nChanel Hastings\nMedia Relations\n+1 (508) 382-0288\nChanel.Hastings@bsci.com (mailto:Chanel.Hastings@bsci.com)\n\nLauren Tengler\nInvestor Relations\n+1 (508) 683-4479\nBSXInvestorRelations@bsci.com (mailto:BSXInvestorRelations@bsci.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-participation-in-bernsteins-42nd-annual-strategic-decisions-conference-and-conference-call-discussing-second-quarter-2026-results-302760793.html\n(https://www.prnewswire.com/news-releases/boston-scientific-announces-participation-in-bernsteins-42nd-annual-strategic-decisions-conference-and-conference-call-discussing-second-quarter-2026-results-302760793.html)\n\nSOURCE Boston Scientific Corporation\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/329537/Boston_Scientific_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-05-04T12:00:17.354531125Z","server_sent_at_ms":1777896017354},"received_at":"2026-05-04T12:00:17.414Z","source_url":null},"analysis":{"id":"13778","press_release_id":"18950","analysis_json":{"industry":{"label":"Health Care Equipment & Services","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Boston Scientific announced that Chairman and CEO Mike Mahoney will represent the company at Bernstein's 42nd Annual Strategic Decisions Conference on May 27, 2026.\n\nThe company also scheduled its second quarter 2026 earnings conference call for Wednesday, July 29, 2026, at 8:00 a.m. ET, hosted by Mahoney and CFO Jon Monson.\n\nFull financial results for the quarter ended June 30, 2026, will be issued prior to the call.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Calendar update only."},"keyFigures":{},"quotedText":"","namedEntities":{"people":[{"name":"Mike Mahoney","role":"Chairman and Chief Executive Officer"},{"name":"Janar Sathananthan","role":"Chief Medical Officer, Interventional Cardiology Therapies"},{"name":"Jon Monson","role":"Executive Vice President and Chief Financial Officer"}],"products":[],"companies":[{"name":"Boston Scientific Corporation","ticker":"BSX"},{"name":"Bernstein","relationship":"conference host"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine administrative announcement regarding conference participation and earnings call scheduling. No material financial or business disclosures made."},"tickerRelevance":{"others":[],"primary":"BSX"},"globalImportance":15,"audienceRelevance":40,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"large-cap","eventGravity":"routine-calendar-update","sectorWeight":"high"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Boston Scientific announced that Chairman and CEO Mike Mahoney will represent the company at Bernstein's 42nd Annual Strategic Decisions Conference on May 27, 2026.\n\nThe company also scheduled its second quarter 2026 earnings conference call for Wednesday, July 29, 2026, at 8:00 a.m. ET, hosted by Mahoney and CFO Jon Monson.\n\nFull financial results for the quarter ended June 30, 2026, will be issued prior to the call.","key_figures":{},"named_entities":{"people":[{"name":"Mike Mahoney","role":"Chairman and Chief Executive Officer"},{"name":"Janar Sathananthan","role":"Chief Medical Officer, Interventional Cardiology Therapies"},{"name":"Jon Monson","role":"Executive Vice President and Chief Financial Officer"}],"products":[],"companies":[{"name":"Boston Scientific Corporation","ticker":"BSX"},{"name":"Bernstein","relationship":"conference host"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:a2703c5a1b5285fe","schema_hash":"sha256:1f8af1196c7db48c","created_at":"2026-05-04T15:33:05.768Z","global_importance":15,"audience_relevance":40,"importance_components":{"tickerTier":"large-cap","eventGravity":"routine-calendar-update","sectorWeight":"high"}},"durationMs":21743,"modelName":"glm-4.7"}}